Arbutus Biopharma Corp SEC filings ABUS
Arbutus Biopharma Corp has 1,000 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| S-8 | Employee stock plan registration | Aug 3, 2023 | — |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| 424B5 | Prospectus supplement | Mar 3, 2022 | — |
| S-3 | Shelf registration | Nov 4, 2021 | — |
| 424B5 | Prospectus supplement | Oct 8, 2021 | — |
| S-8 | Employee stock plan registration | Aug 5, 2021 | — |
| 424B5 | Prospectus supplement | Mar 4, 2021 | — |
| S-3 | Shelf registration | Aug 28, 2020 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| S-8 | Employee stock plan registration | Jun 24, 2020 | — |
| S-3 | Shelf registration | Dec 23, 2019 | — |
| S-8 | Employee stock plan registration | Aug 9, 2019 | — |
| 424B5 | Prospectus supplement | Dec 20, 2018 | — |
| S-8 | Employee stock plan registration | Dec 20, 2018 | — |
| 424B2 | Prospectus | Jan 20, 2017 | — |
| S-3/A | Filing | Jan 12, 2017 | — |
| S-3 | Shelf registration | Dec 23, 2016 | — |
| S-8 | Employee stock plan registration | Jun 20, 2016 | — |
| 424B5 | Prospectus supplement | Mar 20, 2015 | — |
| S-3MEF | Filing | Mar 19, 2015 | — |
| 424B5 | Prospectus supplement | Mar 19, 2015 | — |
| S-8 | Employee stock plan registration | Mar 13, 2015 | — |
| S-3/A | Filing | Dec 10, 2014 | — |
| S-3 | Shelf registration | Nov 26, 2014 | — |
| F-10/A | Filing | Feb 28, 2014 | — |
| F-X | Form f-x | Feb 21, 2014 | — |
| F-10 | Form f-10 | Feb 21, 2014 | — |
| S-8 | Employee stock plan registration | Jan 24, 2013 | — |
| F-10/A | Amendment #1 to form f-10 | Jan 16, 2013 | — |
| F-X | Form f-x | Jan 4, 2013 | — |
| F-10 | Form f-10 | Jan 4, 2013 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABUS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Warminster, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1447028
- Former names
- TEKMIRA PHARMACEUTICALS CORP (until Aug 3, 2015); TEKMIRA PHARMACEUTICALS Corp (until Aug 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.